Therapeutic effects of Spironolactone (Sp) on hepatic fibrosis in BDL rats.
- Wei Luo (80175)
- Ying Meng (327793)
- Hong-Li Ji (327796)
- Chun-Qiu Pan (327799)
- Shan Huang (282228)
- Chang-Hui Yu (327802)
- Li-Ming Xiao (327803)
- Kai Cui (239147)
- Shu-Yuan Ni (327804)
- Zhen-Shu Zhang (327805)
- Xu Li (23864)
Publication date
February 2013
DOIAbstract
<p>Histological images of rat livers stained with H&E (A) or Masson (B) (magnification 200×). Liver fibrosis scores (C) and Semiquantitative measurement of Masson staining (D) in spironolactone or vehicle-treated BDL rats. *<i>p</i><0.05 compared to the Sham group. #<i>p</i><0.05 compared to the BDL groups.</p
Add to ORKG